Trepibutone
ALIMENTARY TRACT AND METABOLISM
Also known as: supacal, trepionate
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Trepibutone is a drug catalogued in DrugCentral. Recorded indications include Pancreatitis.
- Indications: Pancreatitis.
- ATC code: A03AX09 (Other drugs for functional gastrointestinal disorders).
- Molecular formula: C16H22O6; molecular weight 310.35 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Pancreatitis
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
A03AX09 | ALIMENTARY TRACT AND METABOLISM › DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS › DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS › Other drugs for functional gastrointestinal disorders |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Trepibutone is on its molecule page.
| Molecular formula | C16H22O6 |
|---|---|
| Molecular weight | 310.35 g/mol |
| CAS number | 41826-92-0 |
| InChIKey | YPTFHLJNWSJXKG-UHFFFAOYSA-N |
| PubChem CID | 5536 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Trepibutone used for?
DrugCentral lists the following indications for Trepibutone: Pancreatitis.
What is the chemical formula of Trepibutone?
Trepibutone has the molecular formula C16H22O6 and a molecular weight of 310.35 g/mol.
Browse: all drugs starting with T · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 2719 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1725880 — compound record and bioactivity
- PubChem CID 5536 — chemical identifiers
- DrugBank DB13311 — drug record
- FDA UNII H1187LU49Q — substance identity
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.